More than a decade after the Drug Quality and Security Act (DQSA) of 2013 created the 503B category, the central question ...
Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...
Following Hims & Hers’ Super Bowl ad for its weight loss product, a debate has emerged over the safety of compounded GLP-1s for patients. Compounded GLP-1s are custom-made by compounding pharmacies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results